Small Animal Imaging Market Share

Small Animal Imaging Market Overview

The Small Animal Imaging Market size is expected to reach USD 14.9 Billion by 2032 at 6.2% CAGR during the forecast period 2023-2032. Small animal imaging is a technique that uses imaging equipment and reagents to monitor molecular or cellular processes in animals such as rats and mice for drug development and gene expression research.

However, regulatory rules governing the use of animals in investigations, as well as the expensive cost of equipment, may limit the expansion of the small animal imaging industry. The growing need for non-invasive small animal imaging techniques, as well as technical breakthroughs in the sector, is propelling the market forward. Furthermore, major market players are concentrating on launching new products on a regular basis, which is expected to contribute to market growth.

Research Methodology

Market Research Future research is conducted by industry experts who offer insight into industry structure, market segmentation, Treatment assessment, competitive landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments & categories geographically presented are studied and are estimated based on primary & secondary research.

• Primary Research

The extensive primary research was conducted to gain a deeper insight into the market and the industry performance. In this particular report, we have conducted primary surveys (interviews) with the key level executives (VP, CEO's, Marketing Director, Business Development Manager and many more) of the major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.

• Secondary Research

Secondary research was mainly used to collect and identify information useful for an extensive, technical, market-oriented, and commercial study of the small animal imaging market. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, & developments related to the market and Treatment Perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company websites, the international organization of chemical manufacturers, some paid databases and many others.

Segmentation

The small animal imaging market is segmented on the basis of the modality and reagents.

On the basis of the modality, the market is classified into optical imaging systems, nuclear imaging systems, micro-MRI systems, micro-ultrasound systems, micro-CT systems, photoacoustic imaging systems, and Magnetic Particle Imaging (MPI) systems. The optical imaging systems are further segmented into bioluminescence/ fluorescence imaging systems, standalone fluorescence imaging systems, and optical + X-Ray/optical + CT systems. The nuclear imaging systems are segmented into micro-Pet systems, micro-spect systems, and trimodality (spect/pet/CT) systems. The micro-pet system is further segmented into standalone pet systems, pet/CT system, and pet/MRI systems. The micro-spect system is further segmented into standalone spect systems, spect/CT system, and spect/MRI systems.

On the basis of reagent, the market is segmented as optical imaging reagents, nuclear imaging reagents, MRI contrast agents, ultrasound contrast agents, and CT contrast agents. The optical imaging reagents are further segmented as bioluminescent imaging reagents and fluorescent imaging reagents. The bioluminescent imaging reagents are further segmented into luciferins, pro-luciferins, coelenterazine, and other bioluminescent imaging reagents. The fluorescent imaging reagents are further segmented as green fluorescent proteins, red fluorescent proteins, infrared dyes, other fluorescent imaging reagents. The nuclear imaging reagents are segmented into pet tracers and spect probes. The pet tracers are further classified into fluorine-18-based small animal pet tracers, carbon-11-based small animal pet tracers, copper-64-based small animal pet tracers, and other spect probes. The spect probes are further segmented into technetium-99m-based small animal spect probes, iodine-131-based small animal spect probes, gallium-67-based small animal spect probes, thallium-201-based small animal spect probes, and other spect probes. The MRI contrast agents are segmented into gadolinium-based small animal contrast agents, iron-based small animal contrast agents, and manganese-based small animal contrast agents. The CT contrast agents are further segmented into iodine-based small animal CT contrast agents, barium-based small animal CT contrast agents, gold nanoparticles and gastrografin-based small animal CT contrast media.

Geographically, the market has been segmented into America, Europe, Asia Pacific, and the Middle East & Africa. The Americas small animal imaging market is further segmented into North America, and South America. North America is further classified as U.S. and Canada.

The Europe small animal imaging market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, U.K., Italy, Spain, and the Rest of Western Europe. 

The Asia Pacific small animal imaging market is segmented into Japan, China, India, Republic of Korea, Australia, and the Rest of Asia Pacific.

The Middle East & Africa small animal imaging market is segmented into the Middle East and Africa.

Regional Market Summary

The Americas is likely to dominate the global small animal imaging market owing to investments by clinical research organizations in pre-clinical studies, increasing government funding in research activities and increasing number of pharmaceutical and research-based organizations. For instance, the National Institute of Health (NIH) received 1 Billion USD, in the year 2015 for life science and health-related research and development programs. Moreover, the presence of leading market players such as PerkinElmer Inc., Bruker Corporation, Trifoil Imaging, and LI-COR Biosciences within the region contributes to the market growth.

Europe is expected to hold the second position in the global small animal imaging market. The market growth is attributed to rising R&D investments by pharmaceutical companies and growing number of research organizations for diagnosis of diseases. For instance, the European Commission stated that the R&D spending by pharmaceuticals and biotechnology sector grew by 8.7% in 2021.

The Asia Pacific is the fastest growing region in global small animal imaging market. The developing countries such as China and India are offering high growth opportunities for the small animal imaging market players. Moreover, increasing government support for biotechnology and pharmaceutical R&D and growing number of translational research activities contributes to the market growth.

The Middle East & Africa holds the lowest share of the global small animal imaging market due to low development in the healthcare sector, lack of technical knowledge, and poor medical facilities.

Key Players

Some of the key players in the global small animal imaging  market are PerkinElmer Inc. (U.S.) Bruker Corporation (U.S.), FUJIFILM Holdings Corporation (Japan), Mediso Ltd. (Hungary), MILabs B.V. (Netherlands), MR Solutions Ltd. (U.K.), Aspect Imaging (Israel), LI-COR Biosciences (U.S.), Trifoil Imaging (U.S.) and Miltenyi Biotec GmbH (Germany).

Small Animal Imaging Market, by Modality

• Optical Imaging Systems




• Bioluminescence/Fluorescence Imaging Systems


• Standalone Fluorescence Imaging Systems


• Optical + X-Ray/Optical + CT Systems




• Nuclear Imaging Systems


• Micro-PET Systems

• Standalone Pet Systems


• Pet/CT Systems


• Pet/MRI Systems

• Micro-SPECT Systems

• Standalone Spect Systems


• Spect/CT Systems


• Spect/MRI Systems

• Trimodality (SPECT/PET/CT) Systems




• MRI Systems


• Ultrasound Systems


• CT Systems


• Photoacoustic Imaging Systems


• Magnetic Particle Imaging (MPI) Systems

Small Animal Imaging Market, by Reagents

• Optical Imaging Reagents




• Bioluminescent Imaging Reagents

• Luciferins


• Pro-luciferins


• Coelenterazine


• Other bioluminescent imaging reagents

• Fluorescent Imaging Reagents

• Green Fluorescent proteins


• Red fluorescent proteins


• Infrared Dyes


• Other Fluorescent imaging reagents

• Nuclear Imaging Reagents




• PET Tracers

• Fluorine-18-Based Small Animal Pet Tracers


• Carbon-11-Based Small Animal Pet Tracers


• Copper-64-Based Small Animal Pet Tracers


• Other Pet Tracers

• SPECT Probes

• Technetium-99m-Based Small Animal Spect Probes


• Iodine-131-Based Small Animal Spect Probes


• Gallium-67-Based Small Animal Spect Probes


• Thallium-201-Based Small Animal Spect Probes


• Other Spect ProbesFluorine-18-Based Small Animal Pet Tracers

• MRI Contrast Agents




• Gadolinium-based Preclinical MRI Contrast Agents


• Iron-based Preclinical MRI Contrast Agents


• Manganese-based Preclinical MRI Contrast Agents




• Ultrasound Contrast Agents


• CT Contrast Agents




• Iodine-based Preclinical CT Contrast Agents


• Barium-based Preclinical CT Contrast Agents


• Gold Nanoparticles


• Gastrografin-based Preclinical CT Contrast Agents

Small Animal Imaging Market, by Region

• Americas


• North America


• U.S.


• Canada


• South America


• Europe


• Western Europe


• Germany


• France


• Italy


• Spain


• U.K.


• Rest of Western Europe


• Eastern Europe


• Asia Pacific


• Japan


• China


• India


• Australia


• Republic of Korea


• Rest of Asia Pacific


• The Middle East & Africa


• Middle East


• Africa

Company Profiles

• PerkinElmer, Inc.


• Bruker Corporation


• Fujifilm Holdings Corporation


• Medisco Ltd.


• Milabs B.V.


• MR Solutions Ltd.


• Aspect Imaging Ltd.


• Li-Cor Biosciences


• Trifoil Imaging


• Miltenyi Biotech GmbH

Recent Development

PerkinElmer, Inc., formerly Perkin-Elmer, is an American multinational organization that specializes in diagnostics, life science research, food, environmental, and industrial testing. For a variety of end markets, PerkinElmer manufactures analytical equipment, genetic testing, and diagnostic tools, medical imaging components, software, devices, and consumables. PerkinElmer is an S & P 500 company with operations in 190 countries.

Molecular biology, chemistry, computer science, engineering, and medicine are all involved in molecular imaging. Optical imaging (either by bioluminescence or fluorescence), computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), single-photon emission computed tomography (SPECT), and ultrasound have all been used to monitor structural, functional, and molecular changes in cancer tissues (US). In 2021, the company said, the worldwide molecular imaging market is predicted to be worth the US $4,309.0 million, growing at a CAGR of 5.4 percent over the forecast period (2021–2028).Intended Audience

• 
  Preclinical Imaging System Manufacturers, Suppliers, and Imaging Software Providers


• Pharmaceutical and Biotechnology Companies


• Preclinical Imaging Reagent Manufacturers and Suppliers


• 
  Contract Research Organizations (CROs)


• Research and Development (R&D) Companies


• Government Research Laboratories


• Independent Research Laboratories


• Government and Independent Regulatory Authorities


• Market Research and Consulting Service Providers


• Medical Research Laboratories


• Academic Medical Institutes and Universities